These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32409195)

  • 21. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.
    Pinsky PF; Kramer BS
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26483244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.
    Pinsky PF; Gierada DS; Hocking W; Patz EF; Kramer BS
    Ann Intern Med; 2014 Nov; 161(9):627-33. PubMed ID: 25199624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of lung cancer risk model (PLCO
    Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
    Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
    Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial.
    Mascalchi M; Romei C; Marzi C; Diciotti S; Picozzi G; Pistelli F; Zappa M; Paci E; Carozzi F; Gorini G; Falaschi F; Deliperi AL; Camiciottoli G; Carrozzi L; Puliti D
    Eur Radiol; 2023 May; 33(5):3115-3123. PubMed ID: 36854875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
    Barbone F; Barbiero F; Belvedere O; Rosolen V; Giangreco M; Zanin T; Pisa FE; Meduri S; Follador A; Grossi F; Fasola G
    Int J Epidemiol; 2018 Dec; 47(6):1981-1991. PubMed ID: 30325420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung Cancer Screening: Use of Low-Dose Computed Tomography.
    Martínez Pérez E; de Aguiar Quevedo K; Arrarás Martínez M; Cruz Mojarrieta J; Arana Fernández de Moya E; Barrios Benito M; Hinarejos Parga S; Cervera Deval J; Peñalver Cuesta JC
    Arch Bronconeumol (Engl Ed); 2019 Oct; 55(10):526-531. PubMed ID: 31036378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.
    Pastorino U; Boffi R; Marchianò A; Sestini S; Munarini E; Calareso G; Boeri M; Pelosi G; Sozzi G; Silva M; Sverzellati N; Galeone C; La Vecchia C; Ghirardi A; Corrao G
    J Thorac Oncol; 2016 May; 11(5):693-699. PubMed ID: 26921675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
    Goulart BH; Bensink ME; Mummy DG; Ramsey SD
    J Natl Compr Canc Netw; 2012 Feb; 10(2):267-75. PubMed ID: 22308519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
    Pinsky PF; Lynch DA; Gierada DS
    Chest; 2022 Apr; 161(4):1092-1100. PubMed ID: 34838524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
    Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
    PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
    Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
    Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.
    Wang L; Wang Y; Wang F; Gao Y; Fang Z; Gong W; Li H; Zhu C; Chen Y; Shi L; Du L; Li N
    JMIR Public Health Surveill; 2023 Mar; 9():e43586. PubMed ID: 36917151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
    Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
    J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer.
    Wang CL; Hsu KH; Chang YH; Ho CC; Chiang CJ; Chen KC; Cheung YC; Huang PC; Chen YR; Chen CY; Hsu CP; Hsia JY; Chen HY; Yang SY; Li YJ; Yang TY; Tseng JS; Chuang CY; Hsiung CA; Chen YM; Huang MS; Yu CJ; Chen KY; Su WC; Chen JJW; Yu SL; Chen CJ; Yang PC; Tsai YH; Chang GC
    J Thorac Oncol; 2023 Nov; 18(11):1492-1503. PubMed ID: 37414358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.